Page last updated: 2024-09-05

tolvaptan and nephrin

tolvaptan has been researched along with nephrin in 1 studies

Compound Research Comparison

Studies (tolvaptan)	Trials (tolvaptan)	Recent Studies (post-2010) (tolvaptan)	Studies (nephrin)	Trials (nephrin)	Recent Studies (post-2010) (nephrin)
967	172	786	1,130	9	621

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hatamura, I; Kawachi, H; Muragaki, Y; Negi, S; Okada, T; Otani, H; Saji, F; Sakaguchi, T; Shigematsu, T	1

Other Studies

1 other study(ies) available for tolvaptan and nephrin

Article	Year
Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats. Clinical and experimental nephrology, 2009, Volume: 13, Issue:5 Topics: Animals; Antibiotics, Antineoplastic; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Desmin; Humans; Intracellular Signaling Peptides and Proteins; Kidney Glomerulus; Male; Membrane Proteins; Nephrosis; Organ Size; Podocytes; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Tolvaptan; WT1 Proteins	2009

Article

Year

Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.

Clinical and experimental nephrology, 2009, Volume: 13, Issue:5

Topics: Animals; Antibiotics, Antineoplastic; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Desmin; Humans; Intracellular Signaling Peptides and Proteins; Kidney Glomerulus; Male; Membrane Proteins; Nephrosis; Organ Size; Podocytes; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Tolvaptan; WT1 Proteins

2009